Sovaprevir (codenamed ACH-1625) is an experimental drug designed to treat the

hepatitis C virus The hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family ''Flaviviridae''. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer ( hepatoc ...

. It is under

development Development or developing may refer to: Arts *Development (music), the process by which thematic material is reshaped * Photographic development *Filmmaking, development phase, including finance and budgeting * Development hell, when a proje ...

by Achillion Pharmaceuticals. It acts as a NS3/ 4A inhibitor. Sovaprevir received fast track status from the U.S.

Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respo ...

in 2012.

References

External links

Achillion Provides Pipeline Update
Cyclopropyl compounds NS3/4A protease inhibitors 1-Piperidinyl compounds Quinolines Sulfonamides Vinyl compounds {{antiinfective-drug-stub